Skip to content
★ Sign in to follow
MS

Mitchell S. Felder

Premier Biomedical Inc
Total declarations
39
Company
1
▲ Purchases (27 ops.)
€51k
▼ Sales (1 ops.)
€38k

Latest filing published 27 Mar 2020 for PREMIER BIOMEDICAL INC, €4,132.

Filing timeline

BuySale
Mitchell S. Felder

Insider track record

Disclosed buys
27
Disclosed sells
1
Signal history

Closed purchases

Market purchases
27

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Mitchell S. Felder: trading record in brief

This profile gathers the share dealings of Mitchell S. Felder in Premier Biomedical Inc. In total, 39 filings cover trades dated from 25 February 2013 to 27 March 2020.

Both buying and selling appear: 27 purchases worth €51k, against 1 sale worth €38k. On balance, insiders were net buyers of €12k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 5 option exercises. In 2020 alone, the filings show 3 purchases and no sales.

Half of the purchases are above €817 and half below. No cluster: in 24 purchases, no other insider of the company bought within 30 days.

On 27 March 2020 came the latest disclosure, an open-market purchase for €4,132 in Premier Biomedical Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Mitchell S. Felder

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations37 total
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    4,500 USD16SEC
    3,000,000 shares@ US$0.001526.3% of flowCommon StockSEC:0001654954-20-003395:0
    Canonical exit: 24 Jun 2020 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    2,600 USD14SEC
    2,000,000 shares@ US$0.001315.0% of flowCommon StockSEC:0001654954-20-003395:1
    Canonical exit: 25 Jun 2020 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    3,000 USD14SEC
    10,000,000 shares@ US$0.00038.5% of flowCommon stockSEC:0001654954-20-001103:0
    Canonical exit: 3 May 2020 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    100 USD13SEC
    10,000 shares@ US$0.010.3% of flowcommon stockSEC:0001654954-19-010785:0
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    2,187 USD14SEC
    220,955 shares@ US$0.00996.3% of flowcommon stockSEC:0001654954-19-010785:2
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    1 USD13SEC
    100 shares@ US$0.010.0% of flowcommon stockSEC:0001654954-19-010785:3
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    1,900 USD14SEC
    190,000 shares@ US$0.015.4% of flowcommon stockSEC:0001654954-19-010785:4
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    1,688 USD13SEC
    168,845 shares@ US$0.014.8% of flowcommon stockSEC:0001654954-19-010785:5
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    142 USD13SEC
    17,700 shares@ US$0.0080.4% of flowcommon stockSEC:0001654954-19-010785:7
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    800 USD13SEC
    100,000 shares@ US$0.0082.3% of flowcommon stockSEC:0001654954-19-010785:8
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    318 USD13SEC
    39,800 shares@ US$0.0080.9% of flowcommon stockSEC:0001654954-19-010785:9
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    177 USD13SEC
    22,100 shares@ US$0.0080.5% of flowcommon stockSEC:0001654954-19-010785:10
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    1,807 USD14SEC
    220,400 shares@ US$0.00825.2% of flowcommon stockSEC:0001654954-19-010785:11
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    2,400 USD12SEC
    300,000 shares@ US$0.0086.9% of flowCommon StockSEC:0001654954-19-010598:0
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    820 USD11SEC
    100,000 shares@ US$0.00822.3% of flowCommon StockSEC:0001654954-19-010598:1
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    2,050 USD12SEC
    250,000 shares@ US$0.00825.9% of flowCommon StockSEC:0001654954-19-010598:2
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    248 USD11SEC
    30,250 shares@ US$0.00820.7% of flowCommon StockSEC:0001654954-19-010598:3
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    10 USD11SEC
    1,207 shares@ US$0.00850.0% of flowCommon StockSEC:0001654954-19-010598:4
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    900 USD11SEC
    100,000 shares@ US$0.0092.6% of flowCommon StockSEC:0001654954-19-010598:5
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    1,490 USD11SEC
    156,892 shares@ US$0.00954.3% of flowCommon StockSEC:0001654954-19-010598:6
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    380 USD11SEC
    40,000 shares@ US$0.00951.1% of flowCommon StockSEC:0001654954-19-010598:7
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    267 USD11SEC
    28,108 shares@ US$0.00950.8% of flowCommon StockSEC:0001654954-19-010598:8
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    5,419 USD9SEC
    742,356 shares@ US$0.007315.2% of flowCommon StockSEC:0001654954-19-009055:0
    Canonical exit: 5 Nov 2019 (T+90)
  • ▲
    Chairman of the BoardExecutivesPremier Biomedical Inc
    1,881 USD8SEC
    257,644 shares@ US$0.00735.3% of flowCommon StockSEC:0001654954-19-009055:1
    Canonical exit: 5 Nov 2019 (T+90)
  • ◇
    DirectorExecutivesPremier Biomedical Inc
    0SEC
    12,000 shares0Common StockSEC:0001654954-18-012072:0

25 of 37 declarations